Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (295)
- Advertising (25)
- Safety monitoring and information (23)
- Manufacturing (11)
- Scheduling (national classification system) (10)
- COVID-19 (7)
- Clinical trials (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
567 result(s) found, displaying 51 to 75
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 14 March 2024
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsRead our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Meeting statementsCommunique from the meeting of the TGACC
-
Corporate reportsWe commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsRead the meeting statement from 10 October 2024 meeting of the Advisory Committee on Medical Devices
-
Meeting statementsA meeting statement from the second meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
-
Meeting statementsFind out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2025.
-
Meeting statementsCommunique from the 7th meeting of the WHPWG 30 July 2024
-
Meeting statementsRead key points of discussion from the meeting 14 of the Medical Devices Consumer Working Group (MDCWG).
-
Meeting statementsThe 80th meeting of the Advisory Committee on Medical Devices (ACMD), 8 August 2024.
-
Corporate reportsRead our business plan 2024-25 to find out about our strategic priorities and activities.
-
Corporate reportsFind out how we are managing shortages of medicines and taking action to limit their effects. Read our 2024 report.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsDocuments released under the FOI Act in the 2023/24 financial year
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsRead the meeting statement from 27 June 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
-
Corporate reportsThis Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
Meeting statementsCommunique from the 6th meeting of the WHPWG, 27 March 2024
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 47, held on 31 January 2024.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement for meeting 48 held on 1 May 2024.
-
Corporate reportsThis framework outlines our processes to identify and manage risk relating to breast implants.
-
Corporate reportsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.